Tuesday, May 4, 2010

Indications: U.S. stocks fall sharply in sympathy with Europe

Stock Assault 2.0 - Artificial Intelligence Stock Market Software Alert Email Print

By Steve Goldstein & Kate Gibson, MarketWatch

NEW YORK (MarketWatch) -- U.S. stock futures dropped sharply Tuesday as renewed worries over European national debts overrode another round of positive quarterly reports from companies including drug giants Pfizer Inc. and Merck & Co.

"The overseas markets are weighing on sentiment right now, and bond markets around the world are rallying. At least for the morning that is going to be the story," said Dan Greenhaus, chief economic strategist at Miller Tabak.

Futures for the Dow Jones Industrial Average fell 90 points to 11,012. Those for the S&P 500 were down 12.3 points at 1,186.30, while Nasdaq 100 futures declined 23.5 points to 2,003.5.

Greenhaus pointed to a proposal in Australia to tax miners, relatively poor manufacturing data out of China, and concern that Spain is preparing to ask the International Monetary Fund for financial aid as among the bearish factors.

"As that's a much larger economy that Greece, that is weighing as well," he said of the worries regarding Spain.

At least for the morning, Greenhaus said he expected the overseas concerns to override positive earnings from companies including MasterCard Inc. /quotes/comstock/13*!ma/quotes/nls/ma (MA 250.82, +0.08, +0.03%) , which reported a first-quarter profit rise of 24%.

TODAY'S INTERNATIONAL MARKET STORIES

Global Dow

• MarketWatch Topics: Greece • Asia Markets | Europe Markets | LatAm Markets • Canadian Markets | Israel Stocks | London • U.S.: Market Snapshot | After Hours

Tools• Latin American/Canadian indexes • European indexes | Asian indexes

More on the Markets • Bond Report | Oil News | Earnings Watch • Currencies | U.S. Economic Calendar

Earnings • Teva net climbs 58% as Copaxone sales rise • UBS returns to profit on fixed-income • Alstom raises payout 11% as profit grows 10%

/conga/story/misc/international.html 74626

The economics calendar features pending home sales for March, though economists note the report should be particularly strong due to the expiration of a tax credit. Factory orders data is also on tap.

Treasury Secretary Geithner will be testifying on bank reform efforts.

Overseas, Australian stocks dropped after the Reserve Bank of Australia made its third rate hike in a row and as a proposed tax continued to weigh on the resource sector. Tokyo was shut for a holiday.

Worries about sovereign debt weighed on European equities, with the Stoxx Europe 600 sliding 0.9% in late morning trade. Greece hired Lazard /quotes/comstock/13*!laz/quotes/nls/laz (LAZ 38.86, -0.79, -1.99%) for financial advice though the bank said a restructuring of debt "has never been an option to be considered."

The euro /quotes/comstock/21o!x:seurusd (CUR_EURUSD 1.3039, -0.0148, -1.1223%) was down 0.7% as well as the concerns over the Greek rescue package continue.

"The package as it now stands is certainly to be welcomed and may have assuaged market concerns had it been announced three to four months ago," said Michael Hart, a strategist at Citi. "But at this point, the situation has developed from a mere Greece-crisis into a full blown euro-zone sovereign crisis. And European policymakers continue to trail events in formulating their response."

A number of quarterly results were reported. Stock market laggards Pfizer /quotes/comstock/13*!pfe/quotes/nls/pfe (PFE 17.27, +0.36, +2.14%) and Merck /quotes/comstock/13*!mrk/quotes/nls/mrk (MRK 35.98, +0.71, +2.01%) both reported declining profits after making hefty mergers but also topped earnings estimates. Pfizer shares rose 1.8% in premarket trade while Merck edged 0.1% lower.

Interactive Data Corp. /quotes/comstock/13*!idc/quotes/nls/idc (IDC 33.23, +0.24, +0.73%) reached a deal to be purchased by private-equity groups Silver Lake Partners and Warburg Pincus for $3.4 billion. Majority owner Pearson /quotes/comstock/13i!pso/quotes/nls/pso (PSO 15.47, -0.84, -5.15%) will receive $2 billion before tax from the deal.

U.S. stocks climbed strongly on Monday, recapturing much of Friday's sharp slide, as a reporting showing rising consumer spending as well as improving car sales helped equities recapture much of Friday's nosedive. The Dow Jones Industrial Average rose 143 points, and the S&P 500 closes above the key 1,200 level in its best one-day showing since March 5.

Steve Goldstein is MarketWatch's London bureau chief. Kate Gibson is a reporter for MarketWatch, based in New York.


Indications: U.S. stock futures dip on renewed Europe jitters

Stock Assault 2.0 - Artificial Intelligence Stock Market Software Alert Email Print

By Steve Goldstein, MarketWatch

LONDON (MarketWatch) -- U.S. stock futures dropped Tuesday on renewed worries over European national debts as drug giants Pfizer and Merck both beat analyst estimates on earnings.

S&P 500 futures fell 6.3 points to 1,192.30 and Nasdaq 100 futures fell 11.75 points to 2,015.20. Futures on the Dow Jones Industrial Average fell 46 points.

TODAY'S INTERNATIONAL MARKET STORIES

Global Dow

• MarketWatch Topics: Greece • Asia Markets | Europe Markets | LatAm Markets • Canadian Markets | Israel Stocks | London • U.S.: Market Snapshot | After Hours

Tools• Latin American/Canadian indexes • European indexes | Asian indexes

More on the Markets • Bond Report | Oil News | Earnings Watch • Currencies | U.S. Economic Calendar

Earnings • Teva net climbs 58% as Copaxone sales rise • UBS returns to profit on fixed-income • Alstom raises payout 11% as profit grows 10%

/conga/story/misc/international.html 74626

The economics calendar features pending home sales for March, though economists note the report should be particularly strong due to the expiration of a tax credit. Factory orders data is also on tap.

Treasury Secretary Geithner will be testifying on bank reform efforts.

Overseas, Australian stocks dropped after the Reserve Bank of Australia made its third rate hike in a row and as a proposed tax continued to weigh on the resource sector. Tokyo was shut for a holiday.

Worries about sovereign debt weighed on European equities, with the Stoxx Europe 600 sliding 0.9% in late morning trade. Greece hired Lazard /quotes/comstock/13*!laz/quotes/nls/laz (LAZ 39.65, +0.99, +2.56%) for financial advice though the bank said a restructuring of debt "has never been an option to be considered."

The euro /quotes/comstock/21o!x:seurusd (CUR_EURUSD 1.3067, -0.0120, -0.9100%) was down 0.5% as well as the concerns over the Greek rescue package continue.

"The package as it now stands is certainly to be welcomed and may have assuaged market concerns had it been announced three to four months ago," said Michael Hart, a strategist at Citi. "But at this point, the situation has developed from a mere Greece-crisis into a full blown euro-zone sovereign crisis. And European policymakers continue to trail events in formulating their response."

A number of quarterly results were reported. Stock market laggards Pfizer /quotes/comstock/13*!pfe/quotes/nls/pfe (PFE 16.91, +0.19, +1.14%) and Merck /quotes/comstock/13*!mrk/quotes/nls/mrk (MRK 35.27, +0.23, +0.66%) both reported declining profits after making hefty mergers but also topped earnings estimates. Pfizer shares rose 1.5% in premarket trade while Merck wasn't yet active.

Interactive Data /quotes/comstock/13*!idc/quotes/nls/idc (IDC 32.99, -0.48, -1.43%) reached a deal to be purchased by private-equity groups Silver Lake Partners and Warburg Pincus for $3.4 billion. Majority owner Pearson /quotes/comstock/13i!pso/quotes/nls/pso (PSO 16.31, +0.34, +2.13%) will receive $2 billion before tax from the deal.

U.S. stocks climbed strongly on Monday, recapturing much of Friday's sharp slide, as a reporting showing rising consumer spending as well as improving car sales helped equities recapture much of Friday's nosedive. The Dow Jones Industrial Average rose 143 points, and the S&P 500 closes above the key 1,200 level in its best one-day showing since March 5.

Steve Goldstein is MarketWatch's London bureau chief.


NYSE Arca Morning Update - 08:30:00 ET

NYSE Arca Morning Update for Tuesday, May 4, 2010 :

STOCKS TRADING ON NYSE Arca AT A PRICE 15% OR MORE AWAY FROM
THE PREVIOUS TRADE DAY'S CONSOLIDATED CLOSE PRICE (AS OF 08:30:00 ET)

Stock Monday's Close Current Price Pct Change Current NYSE ARCA Vol
SAY $5.39 $4.42 (17.9%) 2,000
LF $7.12 $5.96 (16.3%) 9,795
NTRI $18.50 $21.45 15.9% 49,911


10 MOST ACTIVE STOCKS ON NYSE ARCA AS OF 08:30:00 ET

BASED ON DOLLARS TRADED: | BASED ON SHARES TRADED:
Stock $ Volume Price PctChg | Stock Share Vol Price PctChg
SPY $112464272 $119.45 ( 0.8%) | C 3,909,789 $4.36 ( 1.1%)
IDC $46,368,611 $33.22 0.7% | IDC 1,394,050 $33.22 0.7%
QQQQ $36,841,705 $49.50 ( 0.9%) | SPY 941,214 $119.45 ( 0.8%)
GLD $32,682,987 $116.09 0.3% | SIRI 823,800 $1.16 ( 6.5%)
IWM $19,327,416 $72.46 ( 1.1%) | PFE 747,693 $17.23 1.8%
BP $18,425,638 $50.54 0.8% | QQQQ 742,969 $49.50 ( 0.9%)
C $17,011,260 $4.36 ( 1.1%) | BP 366,461 $50.54 0.8%
RTP $15,338,121 $49.16 2.6% | NOK 316,118 $11.96 ( 1.3%)
PFE $12,880,086 $17.23 1.8% | LYG 310,665 $3.85 ( 6.6%)
AAPL $9,294,135 $263.58 ( 1.0%) | RTP 308,754 $49.16 2.6%


Price changes may be affected by symbol splits and dividends.

Consolidated close price is the last print (excluding prints with trade
conditions) prior to 4PM ET.

This information is also updated on our web page every morning at 8:35ET:
http://www.tradearca.com/data/volume/daily_update.asp

This material is for informational purposes only.
NYSE Euronext and its affiliates ("NYSE Arca") are not soliciting any action based upon it.
This material is not to be construed as an offer to buy or sell any security in any jurisdiction where such an offer or solicitation would be illegal.
Any opinions expressed in this material are NYSE Arca opinions only.
NYSE Arca undertakes no obligation to update any of the information contained in this material in light of new information or future events.
THIS MATERIAL IS PROVIDED BY NYSE ARCA "AS IS" AND WITHOUT WARRANTIES EXPRESS OR IMPLIED.
NYSE ARCA DISCLAIMS ALL WARRANTIES INCLUDING THE IMPLIED WARRANTIES OF MERCHANTIBILITY, TITLE, AND FITNESS FOR A PARTICULAR PURPOSE AS TO THIS MATERIAL.
IN NO EVENT SHALL NYSE ARCA BE LIABLE FOR DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER (INCLUDING BUT NOT LIMITED TO, LOST PROFITS, TRADING LOSSES AND DAMAGES THAT MAY RESULT FROM THE USE
OF THIS MATERIAL, ANY DELAY OR INTERRUPTION OF SERVICE OR OMISSIONS OR INACCURACIES IN THE MATERIAL) WITH RESPECT TO THIS MATERIAL.

Copyright [2010] by NYSE Euronext. All rights reserved. Reproduction and redistribution prohibited without prior express consent.

Subscribe to "The $t0ckman" via email

Enter your email address:

Delivered by FeedBurner